Clinical Trials in Germany

• A phase I/IIa, prospective, mono-center, double-blinded, randomized, controlled study to assess the safety and efficacy of applying PLX-PAD … Not authorised
  2023-504212-15-00 Phase I/II Osteoarthritis Charite Universitaetsmedizin Berlin KöR
• Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetr… Not authorised
  2023-504355-28-00 Healthy volunteers Helsinn Birex Pharmaceuticals Limited; Helsinn Healthcare S.A.
• A study to test how either a capsule or a tablet with NDec (Decitabine and Tetrahydrouridine) works in the body of healthy people Not authorised
  2023-504582-22-00 Phase I Sickle Cell Disease Novo Nordisk A/S
• HARMONi-3 Not authorised
  2023-504989-37-00 Phase III Metastatic Squamous Non-small Cell Lung Cancer Summit Therapeutics Sub Inc.
• Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inh… Not authorised
  2023-505311-20-00 Phase III Metastatic Non-Small Cell Lung Cancer Oncoc4 Inc.
• Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno… Not authorised
  2023-506014-47-00 Phase I/II Resected (R0 or R1) pancreatic ductal adenocarcinoma BioNTech SE
• A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Not authorised
  2023-506642-23-00 Phase II Active Pulmonary Sarcoidosis Molecure S.A.
• Clinical validation study of urinary clusterin and EGF in patients with chronic kidney disease Not authorised
  2023-507449-27-00 Phase IV Chronic kidney disease Steno Diabetes Center Copenhagen
• AP01 Heart Failure (AHF) Study Not authorised
  2023-507573-17-01 Phase II Acute Heart Failure Ananda Pharma GmbH
• A Study Providing Continued Access to Treatment in Patients with a Neurological Disease Previously Enrolled in a Genentech and/or F. Hoffman… Not authorised
  2023-507633-21-00 Phase III Neurological Disease F. Hoffmann-La Roche AG
• Metal Panel Patch Test Not authorised
  2023-507972-35-00 Phase III Allergic contact dermatitis Eczema Smarthealth Inc.
• Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D Not authorised
  2023-508054-25-00 Phase I (Other) Type 2 diabetes Nanexa AB
• Efficacy and safety of Escholzia tablets in adults with insomnia: a biphasic study with a randomized, placebo-controlled, double-blind, 1-mo… Not authorised
  2023-508169-34-00 Phase III Insomnia (ICD-10 F51.0) A.Vogel AG
• An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study) Not authorised
  2023-508444-22-00 Phase I Chronic hepatitis B infection Region Midtjylland
• Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Not authorised
  2023-509861-19-00 Phase II Diffuse large B-cell lymphoma (DLBCL) Universitaet Muenster
• Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacok… Not authorised
  2024-510582-42-00 Phase II Acute graft versus host disease (aGvHD) Realta Life Sciences Inc.
• A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors pr… Not authorised
  2024-512403-39-00 Phase I Advanced Solid Tumors Who Are Beyond Standard of Care Abalos Therapeutics GmbH
• Safety, Tolerability, and Imaging Quality of HarMono-T Contrast Agent During Ultrasound of the Kidney in Healthy Subjects Not authorised
  2024-514924-17-00 Phase I/II Ultrasound contrast agent, for diagnostic purposes (to asses… Solstice Pharmaceuticals B.V.
• A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with… Not authorised
  2024-515199-10-00 Phase II Retinitis Pigmentosa Laboratoires Thea
• A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence Not authorised
  2024-515609-25-00 Phase II Glioblastoma Philogen S.p.A.
• Study to Evaluate the Efficacy and Safety of ATI-045 in Atopic Dermatitis Not authorised
  2024-520302-19-00 Phase II Atopic dermatitis Aclaris Therapeutics Inc.
• A prospective, multi-centre, randomised, double-blind, placebo-controlled Phase III trial to investigate the efficacy and safety of lozenges… Not authorised
  2025-521764-35-00 Phase III acute pharyngitis MEDICE Arzneimittel Puetter GmbH & Co. KG
• A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised
  2025-523060-20-00 Phase III Schizophrenia European Group for Research in Schizophrenia Stichting
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 Phase III Ulcerative colitis Merck Sharp & Dohme LLC

Showing 25–48 of 3,911 trials